Gland Pharma to hold investor meetings this week

Gland Pharma Limited is scheduled to hold meetings with institutional investors and analysts on September 11 and 12, 2025. On September 11, the company will conduct a one-on-one meeting with Fidelity International. The following day, September 12, Gland Pharma will host a group meeting involving Ambit Capital and Investec GuruSpeek 2.0.

The purpose of these engagements is to provide updates and discuss the company's performance and future outlook with key financial stakeholders. The announcement, issued on September 8, 2025, emphasizes that the schedule is subject to change based on the exigencies of the participating investors, analysts, or the company itself.

These meetings are in accordance with Regulation 30 read with Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, ensuring transparency in investor relations. Sampath Kumar Pallerlamudi, company secretary & compliance officer, signed the intimation on behalf of Gland Pharma Limited.